Acorda Therapeutics, Inc. Quarterly Return On Equity in % from Q3 2017 to Q1 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Acorda Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2017 to Q1 2024.
  • Acorda Therapeutics, Inc. Return On Equity for the quarter ending March 31, 2024 was 486 %.
  • Acorda Therapeutics, Inc. annual Return On Equity for 2023 was -2.21K %, a 3121% decline from 2022.
  • Acorda Therapeutics, Inc. annual Return On Equity for 2022 was -68.5 %, a 17.4% decline from 2021.
  • Acorda Therapeutics, Inc. annual Return On Equity for 2021 was -58.4 %, a 68.4% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 486 +555 Jan 1, 2024 Mar 31, 2024
Q4 2023 -2.21K -2.14K -3121% Oct 1, 2023 Dec 31, 2023
Q3 2023 -21.5 +74.1 +77.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -26.6 +62.9 +70.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -69.7 -9.68 -16.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -68.5 -10.1 -17.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -95.5 -12.2 -14.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -89.5 -33.8 -60.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -60 -11.7 -24.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -58.4 -23.7 -68.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -83.3 -99.4 -618% Jul 1, 2021 Sep 30, 2021
Q2 2021 -55.7 +18.9 +25.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -48.3 +16 +24.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -34.7 +29.4 +45.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 16.1 +81.7 Jul 1, 2020 Sep 30, 2020
Q2 2020 -74.6 -60.9 -445% Apr 1, 2020 Jun 30, 2020
Q1 2020 -64.2 -63.3 -6587% Jan 1, 2020 Mar 31, 2020
Q4 2019 -64.1 -69.8 -1226% Oct 1, 2019 Dec 31, 2019
Q3 2019 -65.7 -39.8 -154% Jul 1, 2019 Sep 30, 2019
Q2 2019 -13.7 +13.2 +49.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -0.96 +33.9 +97.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 5.69 +40.5 Oct 1, 2018 Dec 31, 2018
Q3 2018 -25.8 -17.7 -216% Jul 1, 2018 Sep 30, 2018
Q2 2018 -26.9 Apr 1, 2018 Jun 30, 2018
Q1 2018 -34.9 Jan 1, 2018 Mar 31, 2018
Q4 2017 -34.8 Oct 1, 2017 Dec 31, 2017
Q3 2017 -8.18 Jul 1, 2017 Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.